Skip to Content

DaVita Inc

DVA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$646.00MbzvyhGrbkfvwnk

DaVita Disappoints in Third Quarter and Reduces 2022-23 Outlook; Shares Moderately Undervalued

Narrow-moat DaVita turned in third-quarter results that were significantly lower than expected, and management pulled down key metrics of its 2022 and preliminary 2023 outlook. Considering these weak near-term prospects, we are reducing our fair value estimate by 7% to $108 per share. Despite this reduction, the shares appear moderately undervalued, especially after the big selloff after the earnings release.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of DVA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center